OpenAlex
PricingAboutJobs
Log inGet started
Work

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru

HTML

Year: 2002
Type: article
Source: The Lancet
DOI: 10.1016/s0140-6736(02)08830-x
Authors: Pedro G Suárez, Katherine Floyd, Jaime Portocarrero, Edith Alarcón, Elisabetta Rapiti, Gilbert Ramos, Cesar Bonilla, Ivan Sabogal, Isabel Aranda, Christopher Dye, Mario Raviglione, Marcos A Espinal
Institutions: Ministry of Health, World Health Organization
Language: English

Topic: Tuberculosis Research and Epidemiology
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Keywords: chronic tuberculosis, multidrug-resistant tuberculosis, cost-effectiveness, medication adherence, treatment outcomes, drug resistance, kanamycin, ciprofloxacin, ethionamide, pyrazinamide, ethambutol, disability-adjusted life years, tuberculosis control program, Peru
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1997662775
FWCI: 10.88
Cites: 25
Cited by: 259
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms